Showing 2,791 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Economic & social inequality

Men in same-sex couples suffer earnings decline when preventative HIV-medicine is available

Editor's pick
EurekAlert
18 August 2022
Transgender people

Injectable PrEP is just as effective for transgender women as it is for gay men, study analysis finds

News
11 August 2022
Injectable & long-acting PrEP

Preventive HIV drug shows urgent need for transparency on pricing

Editor's pick
Nature (editorial)
10 August 2022
Access to healthcare

Texas lawsuit aims to gut birth control and HIV medication coverage from health insurance plans

Editor's pick
The Hill
10 August 2022
Global health initiatives

aidsmapLIVE: AIDS 2022 special Video

August 2022
PrEP science

New data suggest PrEP in pregnancy is safe

News
3 August 2022
Injectable & long-acting PrEP

Injectable PrEP can only cost a little more than oral PrEP if it is to be cost-effective, South African study finds

News
3 August 2022
Access to healthcare

Just six injections a year can prevent HIV: here’s what it will take for the world to afford them

News
2 August 2022
PrEP programmes & uptake

Deliver medication faster to eliminate HIV, Scottish Government told

Editor's pick
The National
2 August 2022
PrEP programmes & uptake

Who, what, where and when: tailoring PrEP services to increase uptake

News
1 August 2022
PrEP programmes & uptake

PrEP inequities have worsened in the US over the last decade, both racially and regionally

News
30 July 2022
PrEP policies & guidelines

WHO recommends long-acting cabotegravir for HIV prevention

Editor's pick
World Health Organization
29 July 2022
Hepatitis C transmission & prevention

Widespread PrEP use is not leading to more hepatitis C transmission among gay and bisexual men

News
29 July 2022
Generic medicines

ViiV Healthcare to allow 90 countries to access generic versions of HIV prevention shot

News
28 July 2022
Injectable & long-acting PrEP

ViiV Healthcare and the Medicines Patent Pool sign new voluntary licensing agreement to expand access to innovative long-acting HIV prevention medicine

Editor's pick
Medicines Patent Pool
28 July 2022
Injectable & long-acting PrEP

UNAIDS welcomes ViiV’s agreement to enable generic production of long acting PrEP to 90 countries

Editor's pick
UNAIDS
28 July 2022
Access to healthcare

Obamacare back in court as Texans challenge coverage for STDs and HIV care

Editor's pick
Politico
28 July 2022
Government, leadership & policy

Obamacare back in court as Texans challenge coverage for STDs and HIV care

Editor's pick
POLITICO
27 July 2022
PrEP

PrEP State of the Union: Adherence, Access, Uptake Issues

Editor's pick
Contagion Live
22 July 2022
Vaginal rings & topical PrEP

Population Council Acquires the Monthly Dapivirine Ring and Other Woman-centered HIV Prevention Technologies from the International Partnership for Microbicides

Editor's pick
Population Council
22 July 2022
People who inject drugs

Pilot project integrates HIV pre-exposure prophylaxis (PrEP) with harm reduction

Editor's pick
CATIE News
21 July 2022
PrEP

Black HIV Advocates Plan Summit to Address PrEP Disparities

Editor's pick
POZ
21 July 2022
Injectable & long-acting PrEP

Injectable and long-acting PrEP A research briefing

About HIV
July 2022
Sexually transmitted infections tests & treatment

How often should PrEP users be tested for STIs?

News
19 July 2022